Poland· PL-100342909
Zykadia
A ceritinib product containing ceritinibum, registered in Poland by Novartis Europharm Limited. The same ATC class is registered in 13 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Ceritinib is registered in 13 of 19 countries.
Countries holding a registration under ATC L01ED02 (ceritinib), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 8 of them publish a price we can compare per daily dose
Ceritinib · ATC L01ED02
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of ceritinib costs, country by country.
Normalised to the WHO defined daily dose (0.45 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Ceritinib · price per daily dose (0.45 g)
USD · FX 28 Sept 2026
- CH Switzerland$188.22
The record
At a glance
URPL (Poland)- Active substance
- Ceritinibum
- Manufacturer
- Novartis Europharm Limited
- Country
- Poland (PL)
- ATC code
- L01ED02
- ATC class
- Ceritinib
- Defined daily dose
- 0.45 g, O
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 1
- gtin05909991220075
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
769 interactions on record for ceritinib.
Graded by severity as the source publishes them — 449 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Ceritinib · interactions on record
769 records
- 449 severe
- 307 moderate
- 13 minor
Most severe, free to view
- PapaverineA03AD01severe
- CisaprideA03FA02severe
- OndansetronA04AA01severe
- GranisetronA04AA02severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Ceritinib in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaZYKADIANovartis Europharm Limited, Dublin
- CanadaZYKADIANOVARTIS PHARMACEUTICALS CANADA INC
- SpainZYKADIA 150 MG CAPSULAS DURASNovartis Europharm Limited
- FinlandZykadiaNovartis Europharm Limited
- FranceZYKADIA 150 mg, géluleNOVARTIS EUROPHARM (IRLANDE)
- United KingdomZykadia 150mg capsulesNovartis Pharmaceuticals UK Ltd
- IrelandZykadia 150 mg hard capsulesNovartis Europharm Limited
- IcelandZykadiaNovartis Europharm Limited*
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Zykadia
- Liechtenstein · Zykadia
- Norway · Zykadia
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/daa7b25c-aabb-4db6-9889-2b42e3128d13 GET /v1/drugs/daa7b25c-aabb-4db6-9889-2b42e3128d13?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Kapsułki twarde",
"source": "urpl",
"strength": "150 mg",
"packaging": "05909991220075 ¦ Rpz ¦ EU/1/15/999/001 ¦ 108186\n150 kaps.\nRpz ¦ EU/1/15/999/002 ¦ 125662\n40 kaps.\nRpz ¦ EU/1/15/999/003 ¦ 131234\n90 kaps.\nRpz ¦ EU/1/15/999/006 ¦ 159066\n150 kaps. (3 x 50 kaps.)\nRpz ¦ EU/1/15/999/005 ¦ 159067\n90 kaps.",
"substance": "Ceritinibum 150 mg",
"common_name": "Ceritinibum",
"pl_product_id": "100342909",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}See everything about ceritinib.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.